0001104659-21-113372.txt : 20211007 0001104659-21-113372.hdr.sgml : 20211007 20210907151427 ACCESSION NUMBER: 0001104659-21-113372 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Future Health ESG Corp. CENTRAL INDEX KEY: 0001851182 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 862305680 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 8 THE GREEN STREET 2: SUITE # 12081 CITY: DOVER STATE: DE ZIP: 19901 BUSINESS PHONE: 833-388-8734 MAIL ADDRESS: STREET 1: 8 THE GREEN STREET 2: SUITE # 12081 CITY: DOVER STATE: DE ZIP: 19901 CORRESP 1 filename1.htm

September 7, 2021

VIA EDGAR

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549-4561

	Re:	Future Health ESG Corp.
		Registration Statement on Form S-1
		File No. 333-258911

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Future Health ESG Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. EST on September 9, 2021, or as soon as thereafter practicable.

Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, in excess of 350 copies of the Preliminary Prospectus dated August 31, 2021 have been or will be distributed to prospective dealers, institutional investors, retail investors and others.

The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.

[signature page follows]

Very truly yours,

CANTOR FITZGERALD AND CO.

By:	/s/ David Batalion
Name: David Batalion
Title: Managing Director, Head of SPACs